Abstract:Purpose: Angiostatin (Angio) and endostatin (Endo) are two potent endothelial cell-specific growth inhibitors that have been shown to substantially inhibit angiogenesis in vivo and tumor growth in several murine or human tumor models. Administration of recombinant proteins in tumor-bearing mice results in significant reduction of tumor growth, and even tumor shrinkage, but requires long-term delivery of large doses of these proteins. Transfection of mammary tumor cell lines with angiogenic inhibitor Angio and Endo genes, however, might provide an effective way to achieve the locally higher expression of these antiangiogenic factors in tumor-bearing mice. Materials and Methods: Single CMV promoter-driven hEndo-Angio pBLAST was transfected into murine Mca-35 mammary tumor cells. Secreted endostatin protein was measured in conditioned medium by Western and ELISA. In vitro tumor cell growth was determined by cell proliferation assay. Primary tumor growth and artificial lung metastasis were compared between Endo-Angio transfectants and vector controls. Tumor total structural (CD31-stained) and functional (DiOC7-perfused) vessels were quantitatively determined in these transfectants. Results: Although clone variation existed in hEndo-Angio transfected MCa-35 tumor cells (one of four Endo-Angio transfected positive clones had similar growth rate to the parent), complete loss of tumorigenicity was seen in half of the inoculated animals (2 out of four clones). Three of four positive clones had significant reduction of tumor size compared with vector controls 14 days after inoculation (702±60 vs 36±10 mm3, P<0.05). hEndo-Angio transfectants also had decreases in artificial lung metastasis compared with vector controls. Reduction of tumor growth and lung metastasis in Endo-Angio transfectants was associated with a significant decrease of CD31-stained (total structural) and DiOC7-perfused vessels (functional) in tumors transfected with Endo-Angio genes. Conclusion: These findings imply that the combined angiostatin and endostatin gene transfection is antiangiogenic in mammary tumors, and has physiologic effects that may also produce synergistic antitumor response when combined with radiation.

Development of lentiviral vectors for antiangiogenic gene delivery

Construction of Recombinant Lentivirus Vector for Tumor Vasoinhibitory Peptide Alphastatin Gene Delivery

In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral Vectors

Long-Term Expression of Angiostatin Suppresses Metastatic Liver Cancer in Mice

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

Effective Gene-Viral Therapy For Telomerase-Positive Cancers By Selective Replicative-Competent Adenovirus Combining With Endostatin Gene

Anti-Tumor Effect Of Lentivirus-Mediated Gene Transfer Of Alphastatin On Human Glioma

Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.

Inhibitory Effects of VEGF-siRNA Mediated by Adenovirus on Osteosarcoma-Bearing Nude Mice

Expression of Angiostatin Cdna in a Murine Fibrosarcoma Suppresses Primary Tumor Growth and Produces Long-Term Dormancy of Metastases.

Anti-Tumor Effect Of Human Endostatin Mediated By Retroviral Gene Transfer In Nude Mice

Single or Double Transfection of Angiostatin and Endostatin Genes Affect Mammary Tumor Growth, Lung Metastasis and Structural and Perfused Vessels

Suppression of Lung Tumor Growth and Metastasis in Mice by Adeno-Associated Virus-Mediated Expression of Vasostatin

Inhibition of Tumor Growth and Metastasis Via Local Administration of Recombinant Human Endostatin Adenovirus

Inhibition of Xenograft Human Glioma Tumor Growth by Lentivirus-Mediated Gene Transfer of Alphastatin.

Retroviral Endostatin Gene Transfer Inhibits Human Colon Cancer Cell Growth in Vivo

A Gene Therapy for Cancer Based on the Angiogenesis Inhibitor, Vasostatin.

Development of a Novel Bivalent Baculovirus Vectors for Complement Resistance and Sustained Transgene Expression and Its Application in Anti-Angiogenesis Gene Therapy.

Inhibition of Angiogenesis and the Growth of Murine Colon Cancer with Recombinant Human Endostatin Adenovirus

Research of the Anti-Tumor Effect of Human Endostatin Mediated by Recombinant Adeno-Associated Virus

Treatment of Pancreatic Carcinoma by Adenoviral Mediated Gene Transfer of Vasostatin in Mice